Literature DB >> 15816900

Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient.

Clinton D Crowder1, Kymberly A Gyure, Cinthia B Drachenberg, Joseph Werner, Robert E Morales, Hans H Hirsch, Emilio Ramos.   

Abstract

We report the case of a 47-year-old man who developed progressive multifocal leukoencephalopathy (PML) after receiving immuno-suppressive therapy for renal transplantation. The patient presented with a focal seizure and cognitive changes 5 months post-transplantation. He was found to have enhancing lesions in the parietal lobe and typical findings of PML in a brain biopsy. Immunosuppression was discontinued and the neurological symptoms gradually resolved over a period of 4 weeks. The patient is free of any neurological symptoms 36 months after the diagnosis of PML and imaging studies demonstrate resolution of the PML lesions. The patient returned to hemodialysis 3 months after immunosuppression was discontinued. We also present a review of the literature on PML in renal transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816900     DOI: 10.1111/j.1600-6143.2005.00800.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

Review 2.  [Infections after organ transplantation].

Authors:  W V Kern; D Wagner; H H Hirsch
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

3.  Progressive neurological deficit in an HIV patient.

Authors:  Nwabundo Nwankwo; Kalpana Yeddula; Jonathan Vogel
Journal:  BMJ Case Rep       Date:  2013-06-13

4.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  Farrah J Mateen; RajaNandini Muralidharan; Marco Carone; Diederik van de Beek; Daniel M Harrison; Allen J Aksamit; Mary S Gould; David B Clifford; Avindra Nath
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

5.  A 41-year-old female with progressive multifocal leukoencephalopathy after liver transplant.

Authors:  Zahra Ahmadinejad; Fatemeh Talebi; Niloofar Ayoobi Yazdi; Fereshteh Ghiasvand
Journal:  J Neurovirol       Date:  2019-05-28       Impact factor: 2.643

6.  Neuropathology of JC virus infection in progressive multifocal leukoencephalopathy in remission.

Authors:  Karen S SantaCruz; Gulmohor Roy; James Spigel; Elaine L Bearer
Journal:  World J Virol       Date:  2016-02-12

Review 7.  Opportunistic infections of the central nervous system in the transplant patient.

Authors:  Bruce A Cohen; Valentina Stosor
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

8.  Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.

Authors:  B O Khatri; S Man; G Giovannoni; A P Koo; J-C Lee; B Tucky; F Lynn; S Jurgensen; J Woodworth; S Goelz; P W Duda; M A Panzara; R M Ransohoff; R J Fox
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

9.  JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Authors:  Nina Khanna; Marcel Wolbers; Nicolas J Mueller; Christian Garzoni; Renaud A Du Pasquier; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Raphael Viscidi; Manuel Battegay; Hans H Hirsch
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Natalizumab for the treatment of relapsing multiple sclerosis.

Authors:  Richard A Rudick; Michael A Panzara
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.